Human liver CYP2B6-catalyzed hydroxylation of RP 73401

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 3, 1997, Pages 1389-1395

  Stevens, Jeffrey C ^a   White, Rebecca B ^a   Hsu, Shih Hsein ^a   Martinet, Michel ^b  

^a Rhône Poulenc Rorer ^*  (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ORPHENADRINE; PICLAMILAST;

ANTIBODY TITER; ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; HYDROXYLATION; HYPOTHESIS; LIVER MICROSOME; MASS SPECTROMETRY; PRIORITY JOURNAL;

ARYL HYDROCARBON HYDROXYLASES; BENZAMIDES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDROXYLATION; KINETICS; LIVER; OXIDOREDUCTASES, N-DEMETHYLATING; PHOSPHODIESTERASE INHIBITORS; PYRIDINES;

EID: 0030988863     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. BENET, L., KROETZ, D. AND SHEINER, L.: Pharmacokinetics: The dynamics of drug absorption, distribution, and elimination. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by L. Goodman, A. Gilman, J. Hardman, A. Gilman and L. Limbird, pp. 3-28, McGraw-Hill Companies, New York, NY, 1996.
2. CASHMAN, J., YANG, Z., YANG, L. AND WRIGHTON, S.: Stereo- and regioselective N-and S-oxidation of tertiary amines and sulfides in the presence of adult human liver microsomes. Drug Metab. Dispos. 21: 492-501, 1993.
3. CHANG, T., WEBER, G., CRESPI, C. AND WAXMAN, D.: Differential activation of cyclophosphamide and ifosphamide by cytochromes P-4502B 3A in human liver microsomes. Cancer Res. 53: 5629-5637, 1993.
4. FORRESTER, L. M., HENDERSON, C. J., GLANCEY, M. J., BACK, D. J., PARK, B. K., BALL, S. E., KETTERINGHAM, N. R., MCLAREN, A. W., MILES, J. S., SKETT, P. AND WOLF, C. R.: Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem. J. 281: 359-368, 1992.
5. GUENGERICH, F. P.: Human cytochrome P450 Enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed., ed. by Paul R. Ortiz de Montellano, pp. 473-535, Plenum Press, New York, 1995.
6. GUO, Z., RAEISSI, S., WHITE, R. AND STEVENS, J.: Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab. Dispos. 28: 390-393, 1997.
7. HEYN, H., WHITE, R. AND STEVENS, J.: Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin. Drug Metab. Dispos. 24: 948-954, 1996.
8. KRONBACH, T., MATHYS, D., GUT, J., CATIN, T. AND MEYER, U.: High performance liquid chromatographic analysis for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase and dextromethorphan O-demethylase in microsomes and purified cytoehrome P450 isozymes of human liver. Anal. Biochem. 162: 24-32, 1987.
9. LOWRY, O. H. , ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
10. MADAN, A., LECLUYSE, E., FORSTER, J., CARROLL, K., LATHAM, J., YANG, D. AND PARKINSON, A.: Identification and characterization of cytoehrome P450 2B6 (CYP2B6) in human liver microsomes and its induction in primary cultures of human hepatocytes (Abstract). Eleventh International Symposium on Microsomes and Drug Oxidations, 1996.
11. MICHAELI, T., BLOOM, T., MARTINS, T., LOUGHNEY, K., FERGUSON, K., RIGGES, M., RODGERS, L., BEAVO, J. AND WIGLER, M.: Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J. Biol. Chem. 268: 12925-12932, 1993.
12. MIMURA, M., BABA, T., YAMAZAKI, H., OHMORI, S., INUI, Y., GONZALEZ, F., GUENGERICH, F. AND SHIMADA, T.: Characterization of cytochrome P-450 2B6 in human liver microsomes. Drug Metab. Dispos. 21: 1048-1056, 1993.
13. NEWTON, D., WANG, R. AND LU, A.: Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23: 154-158, 1995.
14. OMURA, T. AND SATO, R.: The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370-2378, 1964.
15. PECK, C., TEMPLE, R. AND COLLINS, J.: Understanding consequences of concurrent therapies. J. Am. Med. Assoc. 269: 1550-1552, 1993.
16. PFISTER, J.: Rapid, high-yield oxidation of Hantzch-type 1,4-dihydropyridines with ceric ammonium nitrate. Synthesis 8: 689-690, 1990.
17. RAEBURN, D., UNDERWOOD, S., LEWIS, S., WOODMAN, V., BATTRAM, C., TOMKINSON, A., JORDAN, R., SOUNESS, J., WEBBER, S. AND KARLSSON, J.-A.: Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br. J. Pharmacol. 113: 1423-1431, 1994.
18. RING, B., CATLOW, J., LINDSAY, T., GILLESPIE, T., ROSKOS, L., CERIMELE, B., SWANSON, S., HAMMAN, M. AND WRIGHTON, S.: Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine, J. Pharmacol. Exp. Ther. 276: 658-666, 1996.
19. WANG, P., BEAUNE, P., KAMINSKY, L., DANNAN, G., KAHZUBARI, F., LARREY, D. AND GUENGERICH, F.: Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22: 5375-5383, 1983.
20. WRIGHTON, S. AND STEVENS, J.: The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22: 1-21, 1993.